[144] Penumbra, Inc. SEC Filing
Penumbra, Inc. filed a Form 144 notifying an intended sale of 372 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $89,339.52. The filing lists 38,999,129 shares outstanding and an approximate sale date of 08/12/2025 on the NYSE. The 372 shares were acquired as restricted stock in two grants of 186 shares each, dated 03/31/2025 and 06/30/2025, with payment noted as Not Applicable. The filing reports Nothing to Report for securities sold in the past three months and includes the seller's representation that they do not possess undisclosed material adverse information, with reference to Rule 10b5-1 plan language.
Penumbra, Inc. ha depositato un Form 144 notificando l'intenzione di vendere 372 azioni ordinarie tramite Morgan Stanley Smith Barney LLC per un valore complessivo di $89,339.52. Il deposito indica 38,999,129 azioni in circolazione e una data approssimativa di vendita 08/12/2025 sulla NYSE. Le 372 azioni sono state acquisite come azioni vincolate in due assegnazioni da 186 azioni ciascuna, datate 03/31/2025 e 06/30/2025, con pagamento indicato come Non applicabile. Il deposito segnala che non ci sono vendite da riportare negli ultimi tre mesi e include la dichiarazione del venditore di non possedere informazioni materiali negative non divulgate, con riferimento al linguaggio del piano Rule 10b5-1.
Penumbra, Inc. presentó un Form 144 notificando la intención de vender 372 acciones ordinarias a través de Morgan Stanley Smith Barney LLC por un valor total de $89,339.52. La presentación indica 38,999,129 acciones en circulación y una fecha aproximada de venta el 08/12/2025 en la NYSE. Las 372 acciones se adquirieron como acciones restringidas en dos concesiones de 186 acciones cada una, con fechas 03/31/2025 y 06/30/2025, y el pago figura como No aplicable. La presentación informa que no hay ventas que reportar en los últimos tres meses e incluye la declaración del vendedor de no poseer información adversa material no divulgada, con referencia al lenguaje del plan Rule 10b5-1.
Penumbra, Inc.는 Form 144를 제출해 Morgan Stanley Smith Barney LLC를 통해 총액 $89,339.52 상당의 372주 보통주를 매각할 예정임을 통지했습니다. 제출서류에는 발행주식수 38,999,129주와 NYSE에서의 예정 매각일 08/12/2025이 기재되어 있습니다. 해당 372주는 각각 186주씩 두 건의 제한부 주식 부여(부여일 03/31/2025 및 06/30/2025)로 취득되었으며, 결제는 해당 없음으로 표기되어 있습니다. 제출서류는 지난 3개월 동안 보고할 매도 내역이 없음을 명시하고 있으며, 판매자가 공개되지 않은 중요하고 불리한 정보를 보유하고 있지 않음을 Rule 10b5-1 계획 문구를 참조하여 진술하고 있습니다.
Penumbra, Inc. a déposé un formulaire Form 144 notifiant son intention de vendre 372 actions ordinaires via Morgan Stanley Smith Barney LLC pour une valeur totale de $89,339.52. Le dépôt indique 38,999,129 actions en circulation et une date approximative de vente le 08/12/2025 sur le NYSE. Les 372 actions ont été acquises en tant qu'actions restreintes dans deux attributions de 186 actions chacune, datées 03/31/2025 et 06/30/2025, le paiement étant indiqué comme Non applicable. Le dépôt précise qu'il n'y a rien à signaler concernant des titres vendus au cours des trois derniers mois et inclut la déclaration du vendeur selon laquelle il ne détient pas d'informations défavorables matérielles non divulguées, en référence au libellé du plan Rule 10b5-1.
Penumbra, Inc. hat ein Form 144 eingereicht, mit dem der beabsichtigte Verkauf von 372 Stammaktien über Morgan Stanley Smith Barney LLC mit einem Gesamtwert von $89,339.52 mitgeteilt wird. Die Einreichung nennt 38,999,129 ausstehende Aktien und ein ungefähres Verkaufsdatum 08/12/2025 an der NYSE. Die 372 Aktien wurden als Restricted Stock in zwei Grants zu je 186 Aktien erworben (Daten: 03/31/2025 und 06/30/2025), die Zahlung ist als Nicht anwendbar angegeben. Die Meldung gibt an, dass in den letzten drei Monaten nichts zu berichten ist, und enthält die Erklärung des Verkäufers, keine nicht offengelegten wesentlichen nachteiligen Informationen zu besitzen, unter Bezugnahme auf den Wortlaut des Rule-10b5-1-Plans.
- None.
- None.
Insights
TL;DR: Routine insider sale notice—372 shares ($89,339.52) scheduled for 08/12/2025; negligible market impact.
The Form 144 documents an intended sale of 372 common shares valued at $89,339.52 through Morgan Stanley Smith Barney LLC on the NYSE. Against the reported 38,999,129 shares outstanding, this position represents approximately 0.00095% of outstanding common shares, indicating the transaction is immaterial to supply or market liquidity. The filing also confirms no sales in the prior three months, which signals this is an isolated planned disposition of recently acquired restricted stock.
TL;DR: Filing records disposition of restricted stock grants with standard seller certifications; governance implications are routine.
The notice shows two restricted stock grants of 186 shares each acquired on 03/31/2025 and 06/30/2025 and intended for sale in aggregate as reported. The signer asserts no undisclosed material adverse information and references Rule 10b5-1 plan adoption language, which are standard compliance representations on Form 144. There are no indications in the filing of unusual governance or disclosure issues.
Penumbra, Inc. ha depositato un Form 144 notificando l'intenzione di vendere 372 azioni ordinarie tramite Morgan Stanley Smith Barney LLC per un valore complessivo di $89,339.52. Il deposito indica 38,999,129 azioni in circolazione e una data approssimativa di vendita 08/12/2025 sulla NYSE. Le 372 azioni sono state acquisite come azioni vincolate in due assegnazioni da 186 azioni ciascuna, datate 03/31/2025 e 06/30/2025, con pagamento indicato come Non applicabile. Il deposito segnala che non ci sono vendite da riportare negli ultimi tre mesi e include la dichiarazione del venditore di non possedere informazioni materiali negative non divulgate, con riferimento al linguaggio del piano Rule 10b5-1.
Penumbra, Inc. presentó un Form 144 notificando la intención de vender 372 acciones ordinarias a través de Morgan Stanley Smith Barney LLC por un valor total de $89,339.52. La presentación indica 38,999,129 acciones en circulación y una fecha aproximada de venta el 08/12/2025 en la NYSE. Las 372 acciones se adquirieron como acciones restringidas en dos concesiones de 186 acciones cada una, con fechas 03/31/2025 y 06/30/2025, y el pago figura como No aplicable. La presentación informa que no hay ventas que reportar en los últimos tres meses e incluye la declaración del vendedor de no poseer información adversa material no divulgada, con referencia al lenguaje del plan Rule 10b5-1.
Penumbra, Inc.는 Form 144를 제출해 Morgan Stanley Smith Barney LLC를 통해 총액 $89,339.52 상당의 372주 보통주를 매각할 예정임을 통지했습니다. 제출서류에는 발행주식수 38,999,129주와 NYSE에서의 예정 매각일 08/12/2025이 기재되어 있습니다. 해당 372주는 각각 186주씩 두 건의 제한부 주식 부여(부여일 03/31/2025 및 06/30/2025)로 취득되었으며, 결제는 해당 없음으로 표기되어 있습니다. 제출서류는 지난 3개월 동안 보고할 매도 내역이 없음을 명시하고 있으며, 판매자가 공개되지 않은 중요하고 불리한 정보를 보유하고 있지 않음을 Rule 10b5-1 계획 문구를 참조하여 진술하고 있습니다.
Penumbra, Inc. a déposé un formulaire Form 144 notifiant son intention de vendre 372 actions ordinaires via Morgan Stanley Smith Barney LLC pour une valeur totale de $89,339.52. Le dépôt indique 38,999,129 actions en circulation et une date approximative de vente le 08/12/2025 sur le NYSE. Les 372 actions ont été acquises en tant qu'actions restreintes dans deux attributions de 186 actions chacune, datées 03/31/2025 et 06/30/2025, le paiement étant indiqué comme Non applicable. Le dépôt précise qu'il n'y a rien à signaler concernant des titres vendus au cours des trois derniers mois et inclut la déclaration du vendeur selon laquelle il ne détient pas d'informations défavorables matérielles non divulguées, en référence au libellé du plan Rule 10b5-1.
Penumbra, Inc. hat ein Form 144 eingereicht, mit dem der beabsichtigte Verkauf von 372 Stammaktien über Morgan Stanley Smith Barney LLC mit einem Gesamtwert von $89,339.52 mitgeteilt wird. Die Einreichung nennt 38,999,129 ausstehende Aktien und ein ungefähres Verkaufsdatum 08/12/2025 an der NYSE. Die 372 Aktien wurden als Restricted Stock in zwei Grants zu je 186 Aktien erworben (Daten: 03/31/2025 und 06/30/2025), die Zahlung ist als Nicht anwendbar angegeben. Die Meldung gibt an, dass in den letzten drei Monaten nichts zu berichten ist, und enthält die Erklärung des Verkäufers, keine nicht offengelegten wesentlichen nachteiligen Informationen zu besitzen, unter Bezugnahme auf den Wortlaut des Rule-10b5-1-Plans.
FAQ
What does the Penumbra (PEN) Form 144 report?
How many Penumbra shares outstanding are listed in the filing?
When were the shares being sold acquired?
Did the filer report any PEN securities sold in the past three months?
Which broker and exchange are involved in the reported sale?
